Medy-Tox Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Hyun-Ho Jung

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership19.7%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think

Mar 31
Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think

Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares

Feb 27
Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares

Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield

Apr 02
Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield

A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns

Feb 09
A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns

Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend

Dec 18
Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend

CEO

Hyun-Ho Jung (61 yo)

no data

Tenure

Mr. Hyun-Ho Jung serves as the Chief Executive Officer of Medy-Tox Inc. Mr. Hyun obtained Doctor of Science degree from Korea Advanced Institute of Science and Technology.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.